Chen Chen-Hung, Tai Shun-Ban, Chen Hsiang-Cheng, Yang Deng-Ho, Peng Ming-Yieh, Lin Yuh-Feng
Graduate Institute of Clinical Medicine, Taipei Medical University, Taipei 11031, Taiwan ; Division of Rheumatology, Immunology and Allergy, Department of Internal Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, School of Medicine, Tzu Chi University, Hualien 970, Taiwan ; Division of Rheumatology, Immunology and Allergy, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei 11490, Taiwan.
Division of Rheumatology, Immunology and Allergy, Department of Internal Medicine, Armed-Forces Zuoying General Hospital, Kaohsiung 81342, Taiwan.
Biomed Res Int. 2015;2015:939783. doi: 10.1155/2015/939783. Epub 2015 Jul 26.
Fever in systemic lupus erythematosus (SLE) can be caused by infection or flare-up of the disease. This study aimed to determine whether the ratio of the level of erythrocyte-bound C4d to that of complement receptor 1 (C4d/CR1) can serve as a useful biomarker in the differentiation between infection and flare-up in febrile SLE patients.
We enrolled febrile SLE patients and determined the ratio on the day of admission. The patients were divided into 2 groups according to the subsequent clinical course.
Among the febrile SLE patients, those with flare-up had higher ratios and lower C-reactive protein (CRP) levels than those with infection. Cut-off values of <1.2447 and >4.67 for C4d/CR1 ratio and CRP, respectively, were 40.91% sensitive and 100.0% specific for the presence of infection in febrile SLE patients; similarly, cut-off values of >1.2447 and <2.2, respectively, were 80% sensitive and 100% specific for the absence of infection in febrile SLE patients.
The C4d/CR1 ratio is a simple and quickly determinable biomarker that enables the differentiation between infection and flare-up in febrile SLE patients at initial evaluation. Further, when combined with the CRP level, it is useful to evaluate disease activity in SLE patients with infection.
系统性红斑狼疮(SLE)患者发热可能由感染或疾病复发引起。本研究旨在确定红细胞结合C4d水平与补体受体1水平之比(C4d/CR1)能否作为发热SLE患者区分感染与疾病复发的有用生物标志物。
我们纳入了发热SLE患者,并在入院当天测定该比值。根据后续临床病程将患者分为两组。
在发热SLE患者中,疾病复发组的C4d/CR1比值高于感染组,而C反应蛋白(CRP)水平低于感染组。C4d/CR1比值<1.2447和CRP>4.67的临界值对发热SLE患者感染存在的敏感性为40.91%,特异性为100.0%;同样,C4d/CR1比值>1.2447和CRP<2.2的临界值对发热SLE患者无感染的敏感性为80%,特异性为100%。
C4d/CR1比值是一种简单且可快速测定的生物标志物,能够在初始评估时区分发热SLE患者的感染与疾病复发。此外,与CRP水平联合使用时,有助于评估合并感染的SLE患者的疾病活动度。